Figure 1 (Vib02 0012 01)
Vibativ
Product Images NDC 52118-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vibativ (NDC 52118-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Theravance, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – 250 mg/vial Unit Carton (Vib02 0016 02)
This is a drug label for the medication VIBATIV, containing instructions for intravenous infusion. The medication comes in a 25mg vial in a sterile, preservative-free, lyophilized form that must be reconstituted before use. The reconstitution process includes mixing the contents of the vial with sterile water or sodium chloride injection to create a final concentration of 15 mg/mL, which must be further diluted before administration. The label provides the prescribing information and dosage as well, and advises to store the medication refrigerated at 2-8°C.*
Package Label – Principal Display Panel – 750 mg/vial Unit Carton (Vib02 0016 03)
This is a medication guide for Vibativ, which is recommended for intravenous infusion only. It should be diluted before being administered through injection. It contains telavancin hydrochloride equivalent to 750 mg telavancin. This medication needs to be refrigerated and discarded after use. Further details regarding its dosage, reconstitution, and dilution can be found in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
